Dr. Ahmed Almousa

Snapshot Highlights

• Leading Hematologist with 20+ years’ expertise in HSCT treatment.
• Pioneered advanced stem cell transplantation techniques and immunotherapy.
• Authored over 50 peer-reviewed publications and clinical guidelines.
• Recognized for exceptional patient outcomes in complex blood disorders.

Experience & Expertise in Hematology

Dr. Ahmed Almousa is a distinguished hematologist and bone marrow transplant specialist, bringing over two decades of extensive experience to the field. His profound expertise spans the diagnosis and treatment of a wide range of blood cancers and complex hematological conditions. Dr. Almousa is particularly renowned for his proficiency in advanced HSCT treatment (Hematopoietic Stem Cell Transplantation) and his innovative application of stem cell transplantation for both malignant and non-malignant disorders. His practice integrates the latest advancements in medical science, ensuring patients receive cutting-edge care tailored to their unique needs.

Specialization in Stem Cell & Immunotherapy

A true leader in therapeutic innovation, Dr. Almousa specializes in sophisticated stem cell transplantation procedures, including autologous and allogeneic transplants. He possesses deep knowledge in the intricacies of preparing patients for transplant, managing post-transplant care, and mitigating complications. Furthermore, Dr. Almousa is at the forefront of immunotherapy, leveraging the body’s own immune system to combat diseases effectively. His work in this critical area has significantly improved prognoses for patients with challenging conditions, making him a sought-after expert in specialized cancer treatments.

Contributions to Research & Education

Beyond his clinical practice, Dr. Ahmed Almousa is a prolific researcher and dedicated educator. He has significantly contributed to the advancement of hematology through numerous peer-reviewed publications, clinical trials, and presentations at international medical conferences. His research focuses on optimizing HSCT outcomes, developing novel immunotherapy protocols, and understanding the mechanisms of hematological malignancies. Dr. Almousa is committed to training the next generation of hematologists and oncologists, sharing his vast knowledge and fostering excellence in the medical community. His active involvement in professional organizations underscores his commitment to elevating standards of care and fostering collaborative advancements.